Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 14 champion booming stocks to bargain close now. On January 8, Truist Financial expert Srikripa Devarakonda reiterated a Buy standing connected the banal with a stock terms people of $56.

This update is simply a reaffirmation of the firm’s revision connected the banal connected December 9, erstwhile it lifted the terms people to $56 from $35 aft the institution shared encouraging information from the Phase 1 survey of TERN-701, its pb programme to dainty chronic myeloid leukemia (CML).

According to TipRanks, Truist told investors that fixed the efficacy and information illustration demonstrated successful the study, the steadfast sees immense imaginable successful the drug’s ‘frontline’ use. The results showed a 64% large molecular effect complaint by 24 weeks.

On the aforesaid day, Mizuho Securities besides reiterated its Outperform standing connected the stock, with a terms people of $54. The steadfast believes TERN-701 is simply a ‘clear imaginable best-in-disease treatment’ for CML.

During an interrogation with CNBC past month, CEO Amy Burroughs said the institution aimed to person pivotal trials for the cause by the extremity of 2026.

Overall, Wall Street has a bullish outlook connected the banal with a statement Strong Buy rating. Terns Pharmaceuticals, Inc. (NASDAQ:TERN)’s shares person surged by implicit 300% successful the past 3 months, and analysts task a further 42.31% upside, arsenic of the adjacent of January 12, based connected the stock’s one-year mean stock terms people of $53.75.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is simply a biopharmaceutical institution focused connected the improvement of treatments for superior diseases specified arsenic crab and obesity.

While we admit the imaginable of TERN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best S&P 500 Stocks to Buy Now and 11 Most Oversold S&P 500 Stocks Heading into 2026

Disclosure: None.